Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/20/2026 | PUT | $50.00 | 654 | +160 | +32.39% |
| 01/16/2026 | PUT | $49.50 | 51 | +35 | +218.75% |
| 02/20/2026 | CALL | $49.00 | 58 | +35 | +152.17% |
| 05/15/2026 | CALL | $46.00 | 54 | +33 | +157.14% |
| 01/15/2027 | PUT | $42.00 | 606 | +30 | +5.21% |
| 06/18/2026 | CALL | $37.00 | 133 | +23 | +20.91% |
| 01/16/2026 | CALL | $46.00 | 463 | -11 | -2.32% |
| 06/18/2026 | PUT | $50.00 | 235 | -11 | -4.47% |
| 01/16/2026 | CALL | $52.00 | 183 | -17 | -8.50% |
| 05/15/2026 | PUT | $50.00 | 138 | -17 | -10.97% |
| 01/16/2026 | CALL | $47.00 | 3,683 | -22 | -0.59% |
| 01/16/2026 | CALL | $49.00 | 240 | -46 | -16.08% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Dodge & Cox Stock Fund | 2.22% | 45.46M | 1.57B |
| Dodge & Cox Balanced Fund | 0.29% | 5.99M | 206.79M |
| Price (T.Rowe) International Value Equity Fund | 0.16% | 3.28M | 113.2M |
| Vanguard/Primecap Fund | 0.15% | 3.01M | 103.97M |
| Price (T.Rowe) International Value Equity Trust | 0.14% | 2.86M | 98.7M |
| Fidelity Series Large Cap Stock Fund | 0.14% | 2.84M | 97.98M |
| Price (T.Rowe) Overseas Stock Fund | 0.13% | 2.64M | 91.02M |
| American Mutual Fund Inc | 0.08% | 1.74M | 59.98M |
| Fidelity Growth & Income Portfolio | 0.08% | 1.6M | 55.17M |
| Vanguard/Windsor II | 0.08% | 1.57M | 54.09M |
Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
01/13 02:00 pm
GlobeNewswire Inc.
Read moreAnaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
01/08 07:00 pm
GlobeNewswire Inc.
Read moreGSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies
01/07 12:48 pm
Benzinga
Read moreSitryx to attend J.P. Morgan Healthcare Conference 2026 showcasing pipeline of novel small molecule candidates targeting major autoimmune indications
01/06 08:00 am
GlobeNewswire Inc.
Read moreDrugmakers Plan Fresh Price Hikes On 350 Medicines In 2026
12/31 09:59 am
Benzinga
Read moreEvaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out
12/19 01:43 pm
Benzinga
Read moreFDA Approves GSK's Drug, Targets Severe Asthma With Two Doses Per Year
12/17 10:04 am
Benzinga
Read moreGSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients
12/12 12:12 pm
Benzinga
Read moreOxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
12/10 03:00 am
GlobeNewswire Inc.
Read moreAstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report
12/03 01:24 pm
Benzinga
Read moreSpero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/28 09:00 am
GlobeNewswire Inc.
Read moreAsthma and COPD Medicines Market Size to Lead USD 19.32 Bn by 2035
11/26 12:00 pm
GlobeNewswire Inc.
Read moreChronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight
11/24 02:00 pm
GlobeNewswire Inc.
Read moreGSK Unit Tesaro Sues AnaptysBio, Threatening Key Cancer Drug Jemperli Royalties
11/21 09:48 am
Benzinga
Read moreAnaptys Initiates Litigation Against Tesaro, a GSK Subsidiary
11/21 04:50 am
GlobeNewswire Inc.
Read moreSCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
11/19 08:00 am
GlobeNewswire Inc.
Read moreIMU Biosciences announces formation of Scientific Advisory Board
11/13 04:00 am
GlobeNewswire Inc.
Read moreNutraceutical Ingredients Market Size Worth USD 191.04 Bn by 2034
11/07 03:22 am
GlobeNewswire Inc.
Read moreAnti-Inflammatory Drugs Market to Reach USD 274.79 Billion by 2034, Fueled by Rising Innovation and Accessibility
10/31 11:00 am
GlobeNewswire Inc.
Read moreGSK Upgrades 2025 Financial Outlook, CEO Says Positioned Well For 2026
10/29 09:08 am
Benzinga
Read moreHuman Combinatorial Antibody Libraries Market to Surge USD 189.57 Million by 2034, Reports Towards Healthcare
10/24 11:00 am
GlobeNewswire Inc.
Read moreFDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep
10/24 10:23 am
Benzinga
Read moreAlector Announces Results from its Phase 3 Clinical Trial of Potential FTD-GRN Therapeutic
10/21 06:45 pm
GlobeNewswire Inc.
Read moreUK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment
10/17 12:43 pm
Benzinga
Read moreMolecule Therapeutics Market Size, Companies and Emerging Technologies Insight – Towards Healthcare
10/10 09:00 am
GlobeNewswire Inc.
Read moreTop Technology Executives Recognized at the 2025 BayAreaCIO ORBIE Awards
09/26 03:50 pm
GlobeNewswire Inc.
Read moreTrump’s Tariff Gambit: Pharma in the Crosshairs and Global Markets on Edge
09/26 02:54 am
Investing.com
Read moreRobert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
09/26 12:08 am
Benzinga
Read moreInfluenza Vaccine Market Size to Cross USD 16.73 billion by 2034 at 7.02% CAGR
09/25 11:00 am
GlobeNewswire Inc.
Read morePneumococcal Vaccine Market Opportunities and Strategies to 2034 - Pediatric Segment Holds the Major Opportunity in Market Expansion
09/24 12:48 pm
GlobeNewswire Inc.
Read moreNew Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies
09/24 02:30 am
GlobeNewswire Inc.
Read moreMaternal Mental Health Market to Worth USD 126.33 Billion Rising at 28.47% CAGR by 2034
09/19 10:00 am
GlobeNewswire Inc.
Read moreGSK To Pour $30 Billion Into US R&D, Manufacturing Over Five Years
09/17 10:06 am
Benzinga
Read moreSoftware Automation in Research and Development (R&D) Clinical Trials Training Course | Harnessing Automation Technology to Deliver Faster, Cost-Effective Outcomes (Oct 1, 2025)
09/04 10:00 am
GlobeNewswire Inc.
Read moreAcne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034
09/01 10:00 am
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing
08/20 10:00 am
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
08/17 11:34 am
GlobeNewswire Inc.
Read more24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025
08/14 09:06 pm
GlobeNewswire Inc.
Read moreGlobal Cancer Vaccines Market to Surpass USD 15.00 Billion by 2032, Unlocking Over USD 10 Billion in New Growth Opportunities | MarketsandMarkets™.
08/11 09:00 am
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
08/09 11:57 am
GlobeNewswire Inc.
Read moreGlobal Myeloproliferative Disorder Treatment Market is Expected to Showcase an Incremental Growth at a CAGR of ~5% by 2032 | DelveInsight
08/06 01:00 pm
GlobeNewswire Inc.
Read moreITRM Reports Results
08/05 10:22 pm
The Motley Fool
Read moreIDEAYA (IDYA) Q2 Net Loss Improves 27%
08/05 04:23 pm
The Motley Fool
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
08/05 10:00 am
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
08/01 10:00 am
GlobeNewswire Inc.
Read more